<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05107466</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY02001061</org_study_id>
    <nct_id>NCT05107466</nct_id>
  </id_info>
  <brief_title>Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss</brief_title>
  <official_title>Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dartmouth College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is being done to determine whether a test that measures a &quot;Visual Evoked&#xD;
      Potential&quot; can be used in a new way for individuals that have hearing loss. This test&#xD;
      measures the participant's brain's response (so called &quot;brain waves&quot;) to specific visual&#xD;
      images. This study will help the investigators determine whether this test could be used to&#xD;
      improve treatments for patients with hearing loss.&#xD;
&#xD;
      The &quot;Visual Evoked Potential&quot; measurement test is already used in the investigator's&#xD;
      Neurology clinic at Dartmouth Hitchcock Medical Center for various conditions to measure&#xD;
      &quot;early&quot; brain responses that occur in the first 1-2 seconds after a new cue. Our research&#xD;
      aims to explore your brain's response just after that early 1-2 second period by looking at a&#xD;
      specific response called the &quot;P300&quot;. The P300 wave is a brain response to new or different&#xD;
      images or sounds. A visual evoked P300 has not been studied in individuals with hearing loss.&#xD;
&#xD;
      The investigators will also compare the results of this test to standard hearing tests and to&#xD;
      a similar P300 response to different sounds. Finally, the investigators will compare the&#xD;
      results of those tests to a test that uses augmented reality to assess the participant's&#xD;
      hearing function. This includes wearing a headset (like a heavy pair of glasses), and&#xD;
      indicating what the participants heard by pointing to different options simply by looking at&#xD;
      the target.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After being consented to participate in this study, participants will schedule a time,&#xD;
      convenient to the participant, to come to the testing clinic to complete the Visually evoked&#xD;
      potential (VEP) and Auditory evoked potential testing (AEP). If the participant hasn't had a&#xD;
      hearing test in the last 6 months one will be scheduled as well. Participant's vision will be&#xD;
      tested by looking a chart on a wall and identifying appropriate letters.&#xD;
&#xD;
      For the VEP portion of the testing, participants will sit in a comfortable chair and have&#xD;
      electrodes placed at several locations on the participant's scalp. Electrodes are stickers&#xD;
      that connect to a wire that connects to a computer.&#xD;
&#xD;
      Electrodes do not break the skin or commonly cause any discomfort or harm. Participants will&#xD;
      sit for approximately 30 minutes and watch images presented to the participant on a computer&#xD;
      screen while the participant's brain's response (visual) is measured using a computer.&#xD;
&#xD;
      For the AEP testing participants will listen while presented with different sounds. The&#xD;
      investigators will measure participant's brain response's for approximately 30 minutes&#xD;
      (auditory).&#xD;
&#xD;
      The augmented reality testing starts with participants seated comfortably. Participants will&#xD;
      listen to auditory prompts and respond to sentences by looking at the correct target response&#xD;
      displayed in front of the participant.&#xD;
&#xD;
      Participants will also complete a battery of tests in the Audiology clinic that involve&#xD;
      listening and responding to different sounds and patterns. While participants are at the&#xD;
      clinic for testing participants will be asked to complete several questionnaires that ask&#xD;
      about participant's mood and thought processing.&#xD;
&#xD;
      Participants will receive a survey either via email or in the mail shortly after completing&#xD;
      testing in our clinic. Participants can complete this survey at home and return it to the&#xD;
      investigating team via email or pre-paid mail.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 31, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in mean VEP latency as measured by onset time of the P300 wave from time of stimuli presentation.</measure>
    <time_frame>15 minutes</time_frame>
    <description>Difference in P300 VEP latency to odd ball paradigm visual stimuli in good vs poor performing Cochlear implant users as determined by AZBio sentence testing with &lt;60% score qualifying as &quot;poor performance.&quot; Difference in VEP latency will be measured by recording onset time of the P300 signal from time of stimuli presentation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in mean VEP amplitude as measured by the maximum voltage reached by the P300 wave after presentation of stimulus before returning back to zero,</measure>
    <time_frame>15 minutes</time_frame>
    <description>Difference in mean VEP amplitude to odd ball paradigm visual stimuli in good vs poor performing Cochlear implant users as determined by AZBio sentence testing with &lt;60% score qualifying as &quot;poor performance.&quot; Differences in VEP amplitude will be measure by recording maximum voltage reached by the P300 wave after presentation of stimulus before returning back to zero.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in mean AEP latency as measured by onset time of the P300 wave from time of stimuli presentation.</measure>
    <time_frame>15 min</time_frame>
    <description>Difference in P300 VEP latency to odd ball paradigm visual stimuli in good vs poor performing Cochlear implant users as determined by AZBio sentence testing with &lt;60% score qualifying as &quot;poor performance.&quot; Difference in AEP latency will be measured by recording onset time of the P300 signal from time of stimuli presentation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in mean AEP amplitude as measured by the maximum voltage reached by the P300 wave after presentation of stimulus before returning back to zero.</measure>
    <time_frame>15 minutes</time_frame>
    <description>Difference in mean AEP amplitude to odd ball paradigm visual stimuli in good vs poor performing Cochlear implant users as determined by AZBio sentence testing with &lt;60% score qualifying as &quot;poor performance.&quot; Differences in AEP amplitude will be measure by recording maximum voltage reached by the P300 wave after presentation of stimulus before returning back to zero.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in augmented reality testing as measured by the signal-to-noise ratio of the volume (measured in decibels) of spoken sentences to the volume of background noise.</measure>
    <time_frame>30 min.</time_frame>
    <description>Differences in augmented reality testing measures in good vs poor performing Cochlear implant users as determined by AZBio sentence testing with &lt;60% score qualifying as &quot;poor performance.&quot; Differences in augmented reality testing measures will be measured by the signal to noise ration (SNR) of the spoken-sentences volume to background noise volume. Both volumes will be measured in decibels.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Sensorineural Hearing Loss</condition>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Cochlear implant, good performer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>40 adults (&gt;18 y/o) with Cochlear implants at least 6 months post implantation who score &gt;60% on the clinically administered speech understanding score AZBIO (Arizona Bioindustry Association sentence test).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cochlear implant, poor performer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>40 adults (&gt;18 y/o) with Cochlear implants at least 6 months post implantation who score &lt;60% on the clinically administered speech understanding score AZBIO.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>P300 Visually evoked potential</intervention_name>
    <description>Measurement of the late cortical response, P300 potential to visually evoked stimuli using an oddball paradigm.</description>
    <arm_group_label>Cochlear implant, good performer</arm_group_label>
    <arm_group_label>Cochlear implant, poor performer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects will be recruited from the Otolaryngology/ Audiology clinic at DHMC with the&#xD;
             goal of enrolling subjects with a variety of degrees of hearing loss and central&#xD;
             auditory processing dysfunction&#xD;
&#xD;
          -  Age&gt;18 y/o&#xD;
&#xD;
          -  Current and new patients receiving care in the DHMC Otolaryngology clinic or from the&#xD;
             employees of Dartmouth College, DHMC, and the community, as allowed under SARS-Co-V-2&#xD;
             (severe acute respiratory syndrome coronavirus 2) guidelines.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with known brain pathology (e.g., CNS (central nervous system) tumors, CVA&#xD;
             (cerebrovascular accident) diagnosis, etcâ€¦)&#xD;
&#xD;
          -  Patients with known blindness&#xD;
&#xD;
          -  Adults unable to consent&#xD;
&#xD;
          -  Individuals who are not yet adults (infants, children, teenagers)&#xD;
&#xD;
          -  Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James E Saunders</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Surgery, Otolaryngology section, Dartmouth Hitchcock Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily G Pengelly, BS</last_name>
    <phone>(210) 723-1843</phone>
    <email>emily.g.pengelly.med@dartmouth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03766</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Emily G Pengelly, BS</last_name>
      <phone>210-723-1843</phone>
      <email>emily.g.pengelly.med@dartmouth.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 25, 2021</study_first_submitted>
  <study_first_submitted_qc>October 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>James E. Saunders</investigator_full_name>
    <investigator_title>Professor of Otology and Neurotology, Department of Otolaryngology</investigator_title>
  </responsible_party>
  <keyword>cochlear implant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data (IPD) will be available to researchers involved in this study only.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

